Company
Last deal
$200M
Amount
Post-IPO Equity
Stage
26.06.2024
Date
19
all rounds
$865.4M
Total amount
General
About Company
Recursion integrates technology to improve patient lives and industrialize drug discovery.
Industry
Sector :
Subsector :
Also Known As
Recursion Pharmaceuticals, Inc., Recursion
founded date
05.11.2013
Number of employees
Company Type
For Profit
Last funding type
Post-IPO Equity
IPO status
Private
Contacts
location
Phone number
Website URL